8-KEarnings & ResultsExhibits & Filings

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Financial Results (May 11, 2005)

Filed May 11, 2005For Securities:ALNY

Summary

Alnylam Pharmaceuticals, Inc. filed a Form 8-K on May 11, 2005, to report its financial results for the quarter ended March 31, 2005. The filing includes a press release detailing these results, which is furnished as Exhibit 99.1. While specific financial figures are not detailed within the 8-K itself, the filing signifies Alnylam's adherence to regulatory reporting requirements. Investors seeking details on the company's performance for the first quarter of 2005 should refer to the accompanying press release (Exhibit 99.1) for comprehensive information regarding revenues, expenses, net income/loss, and any forward-looking statements or operational updates provided by management.

Key Highlights

  • 1Form 8-K filed on May 11, 2005, by Alnylam Pharmaceuticals, Inc.
  • 2Report covers financial results for the quarter ended March 31, 2005.
  • 3Press release detailing Q1 2005 financial results furnished as Exhibit 99.1.
  • 4The filing is for informational purposes and not deemed 'filed' for Section 18 liability.
  • 5Key operational and financial performance metrics are expected to be found in Exhibit 99.1.
  • 6John M. Maraganore, Ph.D., President and Chief Executive Officer, signed the report.
  • 7Alnylam Pharmaceuticals, Inc. is incorporated in Delaware.

Frequently Asked Questions

The primary purpose of this Form 8-K filing is to announce and provide Alnylam Pharmaceuticals, Inc.'s financial results for the first quarter ended March 31, 2005, as reported in a press release.

The detailed financial results for the quarter ended March 31, 2005, are contained within the press release furnished as Exhibit 99.1 to this Form 8-K filing.

This specific 8-K filing (Item 2.02) focuses on the results of operations and financial condition for the quarter. Any new significant business developments or risk factors would typically be detailed within the press release (Exhibit 99.1) or in subsequent filings.

No, the information in this Form 8-K (including Exhibit 99.1) is furnished, not filed, for purposes of Section 18 of the Exchange Act, meaning it is not subject to the liabilities of that section unless expressly incorporated by reference into other SEC filings.